Drug · DIN 02516187
PROGESTERONE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 19, 2022; first marketed August 19, 2022.
- Drug Identification Number (DIN)
- 02516187
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Progesterone G03DA04
- Class
- Human
- Record last updated
- August 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PROGESTERONE | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 27, 2021: NOC 25939Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies